Finished
Ex Vivo 3D-ultrasound for Oropharyngeal Cancer
NCT06314711 · Copenhagen University Hospital, Rigshospitalet · Updated 19 Sept 2024
- What is being tested
- Ultrasound
- For
- Oropharyngeal Squamous Cell Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 15 people. The full rules are on the registry page.
- Where
- Denmark
- When
- Starts or started 1 Oct 2021, ends 1 Feb 2024. Registered 18 March 2024.
- Results
- None posted yet.
In the researchers' words
Patients with biopsy-verified oropharyngeal squamous cell carcinomas treated with transoral robotic surgery are included. Immediately post-operatively, freshly resected specimens are examined with ex vivo 3D ultrasound (US). Ex vivo 3D US will be used to match US slices of the specimen with corresponding histopathology slices. The US slices will be reviewed by a panel of head and neck surgeons blinded to histopathology. The primary aim is to explore perioperative ex vivo 3D US for oropharyngeal tumor detection, delineation from normal tissue, tumor size and volume, and margin assessment.
Sites
- Dept. of Otorhinolaryngology, Head & Neck Surg, RigshospitaletCopenhagen, Denmark